drugset / Trial / NCT05313100

Sugammadex and Smoker's Neuromuscular Block

NCT05313100

Phase 4 Completed 40 enrolled Duzce University
RandomizedParallel-groupDouble-blindPrevention

Summary

We compared the durations of antagonizing and of the severity of effect of sugammadex used in antagonizing the rocuronium in smoker and non-smoker total 40 patients with using Train of Four(TOF) neuromuscular monitorization.

Timeline

Start
2012-04
Primary completion
2013-01
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sugammadex Other / unclassified 2 mg/kg

Indications

No indication recorded.